Announcements Trials
Browse Landscape

Phase

Phase NA 49Phase 4 26Phase 3 21Phase 2 15Phase 2/3 7Phase 1 4Phase EARLY_PHASE1 2Phase 1/2 1

Status

Completed 4Withdrawn 2Recruiting 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1Breast 1

Conditions

Urologic Neoplasms 1Neoplasms 1Leiomyoma 1Hemorrhage 1Breast Neoplasms 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Completed × Saline Solution × Clear all
NCT03359239 2023-05-16

Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer

Icahn School of Medicine at Mount Sinai

Phase 1 Completed
10 enrolled
Genitourinary

Urologic Neoplasms

NCT02620748 2022-10-13

TA

George Washington University

Phase 1 Completed
60 enrolled

Hemorrhage, Leiomyoma

NCT03502395 2018-04-19

Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion

Assiut University

Phase 1 Completed
80 enrolled
Breast

Breast Neoplasms

NCT01874561 2016-10-10

Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization

Achieve Life Sciences

Phase 1 Completed
155 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡